{"nct_id":"NCT03267940","title":"Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma","status":"TERMINATED","status_verified_date":"2020-01","start_date":"2017-10-02","start_date_type":"ACTUAL","primary_completion_date":"2019-11-11","primary_completion_date_type":"ACTUAL","completion_date":"2019-11-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["HALO"]}